CLINICAL_TRIALS
trial_result
· 2019-01-15
Clinical Trial Update: Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of sebelipase alfa in lysosomal acid lipase deficiency has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Lysosomal Acid Lipase Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2019-01-15